Post-injury conditioning with lipopolysaccharide or lipooligosaccharide reduces inflammation in the brain

Journal of Neuroimmunology

Volumn 256, Issue 1-2, 2013, Pages 28-37

  Bingham, Deborah ^a   John, Constance M ^a,b   Levin, Jack ^a,b   Panter, S Scott ^a,b   Jarvis, Gary A ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; LOS; LPS; Microglia; Neuroprotection; Traumatic brain injury

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; LIPOOLIGOSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; ENCEPHALITIS; IMMUNOSUPPRESSIVE TREATMENT; MALE; MICROGLIA; NEUROPROTECTION; NONHUMAN; POST INJURY CONDITIONING; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD CELL COUNT; BRAIN INJURIES; CELL DEATH; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ECTODYSPLASINS; ENCEPHALITIS; HEMATOCRIT; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICROGLIA; MONOCYTES; RATS; RATS, WISTAR;

EID: 84875364164     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.12.009     Document Type: Article

References (71)

1. Abrous D.N., Koehl M., Le Moal M. Adult neurogenesis: from precursors to network and physiology. Physiol. Rev. 2005, 85:523-569.
2. Adén U., Favrais G., Plaisant F., Winerdal M., Felderhoff-Mueser U., Lampa J., Lelièvre V., Gressens P. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFα pathway and protection by etanercept. Brain Behav. Immun. 2010, 24:747-758.
3. Ajmone-Cat M.A., Cacci E., Minghetti L. Non steroidal anti-inflammatory drugs and neurogenesis in the adult mammalian brain. Curr. Pharm. Des. 2008, 14:1435-1442.
4. Anthony D.C., Bolton S.J., Fearn S., Perry V.H. Age-related effects of interleukin-1β on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997, 120:435-444.
5. Antony P.A., Restifo N.P. CD4+ CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J. Immunother. 2005, 28:120-128.
6. Apicella M.A., Griffiss J.M., Schneider H. Isolation and characterization of lipopolysaccharides, lipooligosaccharides, and lipid A. Methods Enzymol. 1994, 235:242-252.
7. Argaw A.T., Zhang Y., Snyder B.J., Zhao M.L., Kopp N., Lee S.C., Raine C.S., Brosnan C.F., John G.R. IL-1β regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 2006, 177:5574-5584.
8. Arvidsson A., Collin T., Kirik D., Kokaia Z., Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 2002, 8:963-970.
9. Banks W.A., Robinson S.M. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav. Immun. 2010, 24:102-109.
10. Bastide M., Gelé P., Pétrault O., Pu Q., Caliez A., Robin E., Deplanque D., Duriez P., Bordet R. Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance. J. Cereb. Blood Flow Metab. 2003, 23:399-405.
11. Bingham D., John C.M., Panter S.S., Jarvis G.A. Post-injury treatment with lipopolysaccharide or lipooligosaccharide protects rat neuronal and glial cell cultures. Brain Res. Bull. 2011, 85:403-409.
12. Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009, 30:475-487.
13. Bohatschek M., Werner A., Raivich G. Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency. Exp. Neurol. 2001, 172:137-152.
14. Butovsky O., Talpalar A.E., Ben-Yaakov K., Schwartz M. Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective. Mol. Cell. Neurosci. 2005, 29:381-393.
15. Cameron H.A., McKay R.D. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J. Comp. Neurol. 2001, 435:406-417.
16. Clausen F., Hanell A., Israelsson C., Hedin J., Ebendal T., Mir A.K., Gram H., Marklund N. Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 2011, 34:110-123.
17. Conlon P.J., Tyler S., Grabstein K.H., Morrissey P. Interleukin-4 (B-cell stimulatory factor-1) augments the in vivo generation of cytotoxic cells in immunosuppressed animals. Biotechnol. Ther. 1989, 1:31-41.
18. Dalgard C.L., Cole J.T., Kean W.S., Lucky J.J., Sukumar G., McMullen D.C., Pollard H.B., Watson W.D. The cytokine temporal profile in rat cortex after controlled cortical impact. Front. Mol. Neurosci. 2012, 5:1-10. (article 6).
19. Davis A.E., Campbell S.J., Wilainam P., Anthony D.C. Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatment. Eur. J. Neurosci. 2005, 22:2441-2450.
20. Dhuria S.V., Hanson L.R., Frey W.H. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J. Pharm. Sci. 2010, 99:1654-1673.
21. Doetsch F., Alvarèz-Buylla A. Network of tangential pathways for neuronal migration in adult mammalian brain. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:14895-14900.
22. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13632-13637.
23. Eskan M.A., Benakanakere M.R., Rose B.G., Zhang P., Zhao J., Stathopoulou P., Fujioka D., Kinane D.F. Interleukin-1β modulates proinflammatory cytokine production in human epithelial cells. Infect. Immun. 2008, 76:2080-2089.
24. Folkerth R.D., Keefe R.J., Haynes R.L., Trachtenberg F.L., Volpe J.J., Kinney H.C. Interferon-γ expression in periventricular leukomalacia in the human brain. Brain Pathol. 2004, 14:265-274.
25. Frugier T., Morganti-Kossmann M.C., O'Reilly D., McLean C.A. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J. Neurotrauma 2010, 27:497-507.
26. Gennarelli T.A., Tipperman R., Maxwell W.L., Graham D.I., Adams J.H., Irvine A. Traumatic damage to the nodal axolemma: an early, secondary injury. Acta Neurochir. Suppl. (Wien) 1993, 57:49-52.
27. Giulian D., Corpuz M., Chapman S., Mansouri M., Robertson C. Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J. Neurosci. Res. 1993, 36:681-693.
28. Graff C.L., Pollack G.M. Nasal drug administration: potential for targeted central nervous system delivery. J. Pharm. Sci. 2005, 94:1187-1195.
29. Granowitz E.V., Porat R., Mier J.W., Orencole S.F., Kaplanski G., Lynch E.A., Ye K., Vannier E., Wolff S.M., Dinarello C.A. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 1993, 151:1637-1645.
30. Hackett S.J., Thomson A.P., Hart C.A. Cytokines, chemokines and other effector molecules involved in meningococcal disease. J. Med. Microbiol. 2001, 50:847-859.
31. Hansen-Pupp I., Harling S., Berg A.C., Cilio C., Hellström-Westas L., Ley D. Circulating interferon-gamma and white matter brain damage in preterm infants. Pediatr. Res. 2005, 58:946-952.
32. Hastings N.B., Gould E. Rapid extension of axons into the CA3 region by adult-generated granule cells. J. Comp. Neurol. 1999, 413:146-154.
33. He F., Yin F., Peng J., Deng X., Wu L., Zhang C. Molecular mechanism for change in permeability in brain microvascular endothelial cells induced by LPS. J. Cent. South Univ. (Med. Sci.) 2010, 35:1129-1137.
34. Hellewell S.C., Morganti-Kossmann M.C. Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury. Mediators Inflamm. 2012, 356494. (Epub;%2012 Jun 4., 356494).
35. Hyakkoku K., Hamanaka J., Tsuruma K., Shimazawa M., Tanaka H., Uematsu S., Akira S., Inagaki N., Nagai H., Hara H. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 2010, 171:258-267.
36. John C.M., Liu M., Jarvis G.A. Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-α in human monocytes. J. Biol. Chem. 2009, 284:21515-21525.
37. Jones N.C., Prior M.J., Burden-Teh E., Marsden C.A., Morris P.G., Murphy S. Antagonism of the interleukin-1 receptor following traumatic brain injury in the mouse reduces the number of nitric oxide synthase-2-positive cells and improves anatomical and functional outcomes. Eur. J. Neurosci. 2005, 22:72-78.
38. Kedar E., Palgi O., Golod G., Babai I., Barenholz Y. Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-α show improved pharmacokinetics and biological activity and reduced toxicity in mice. J. Immunother. 1997, 20:180-193.
39. Kumar A., Loane D.J. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav. Immun. 2012, 26:1191-1201.
40. Lehotský J., Burda J., Danielisová V., Gottlieb M., Kaplán P., Saniová B. Ischemic tolerance: the mechanisms of neuroprotective strategy. Anat. Rec. (Hoboken) 2009, 292:2002-2012.
41. Lenzlinger P.M., Morganti-Kossmann M.C., Laurer H.L., McIntosh T.K. The duality of the inflammatory response to traumatic brain injury. Mol. Neurobiol. 2001, 24:169-181.
42. Liao W., Lin J.X., Leonard W.J. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr. Opin. Immunol. 2011, 23:598-604.
43. Liu X.F., Fawcett J.R., Thorne R.G., Frey W.H. Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion. Neurosci. Lett. 2001, 308:91-94.
44. McIntosh T.K., Smith D.H., Meaney D.F., Kotapka M.J., Gennarelli T.A., Graham D.I. Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab. Invest. 1996, 74:315-342.
45. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
46. Morganti-Kossmann M.C., Satgunaseelan L., Bye N., Kossmann T. Modulation of immune response by head injury. Injury 2007, 38:1392-1400.
47. Munford R.S. Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?. Infect. Immun. 2008, 76:454-465.
48. Parent J.M. Injury-induced neurogenesis in the adult mammalian brain. Neuroscientist 2003, 9:261-272.
49. Patrone J.B., Stein D.C. Effect of gonococcal lipooligosaccharide variation on human monocytic cytokine profile. BMC Microbiol. 2007, 7:7.
50. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press/Elsevier, Burlington, MA, (pp. Figure 13).
51. Peterson A.A., McGroarty E.J. High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli. J. Bacteriol. 1985, 162:738-745.
52. Piao W., Song C., Chen H., Diaz M.A., Wahl L.M., Fitzgerald K.A., Li L., Medvedev A.E. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-β-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 2009, 86:863-875.
53. Pietropaoli A., Georas S.N. Resolving lung injury: a new role for Tregs in controlling the innate immune response. J. Clin. Invest. 2009, 119:2891-2894.
54. Pinteaux E., Trotter P., Simi A. Cell-specific and concentration-dependent actions of interleukin-1 in acute brain inflammation. Cytokine 2009, 45:1-7.
55. Pridmore A.C., Jarvis G.A., John C.M., Jack D.L., Dower S.K., Read R.C. Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains. Infect. Immun. 2003, 71:3901-3908.
56. Quagliarello V.J., Wispelwey B., Long W.J., Scheld W.M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J. Clin. Invest. 1991, 87:1360-1366.
57. Rock R.B., Gekker G., Hu S., Sheng W.S., Cheeran M., Lokensgard J.R., Peterson P.K. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 2004, 17:942-964.
58. Rosenzweig H.L., Lessov N.S., Henshall D.C., Minami M., Simon R.P., Stenzel-Poore M.P. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 2004, 35:2576-2581.
59. Sanderson K.L., Raghupathi R., Saatman K.E., Martin D., Miller G., McIntosh T.K. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury. J. Cereb. Blood Flow Metab. 1999, 19:1118-1125.
60. Semple J.W., Aslam R., Kim M., Speck E.R., Freedman J. Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood 2007, 109:4803-4805.
61. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11:762-774.
62. Stenzel-Poore M.P., Stevens S.L., King J.S., Simon R.P. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke 2007, 38:680-685.
63. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M.P. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13798-13803.
64. Tehranian R., ndell-Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., Lundkvist J., Iverfeldt K. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J. Neurotrauma 2002, 19:939-951.
65. Thorne R.G., Emory C.R., Ala T.A., Frey W.H. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res. 1995, 692:278-282.
66. Vedder H., Schreiber W., Yassouridis A., Gudewill S., Galanos C., Pollmacher T. Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm. Res. 1999, 48:67-74.
67. Yan E.B., Hellewell S.C., Bellander B.M., Agyapomaa D.A., Morganti-Kossmann M.C. Post-traumatic hypoxia exacerbates neurological deficit, neuroinflammation and cerebral metabolism in rats with diffuse traumatic brain injury. J. Neuroinflammation 2011, 8:147.
68. Yilmaz G., Arumugam T.V., Stokes K.Y., Granger D.N. Role of T lymphocytes and interferon-γ in ischemic stroke. Circulation 2006, 113:2105-2112.
69. Yu I., Inaji M., Maeda J., Okauchi T., Nariai T., Ohno K., Higuchi M., Suhara T. Glial cell-mediated deterioration and repair of the nervous system after traumatic brain injury in a rat model as assessed by positron emission tomography. J. Neurotrauma 2010, 27:1463-1475.
70. Ziebell J.M., Morganti-Kossmann M.C. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30.
71. Zughaier S.M., Tzeng Y.L., Zimmer S.M., Datta A., Carlson R.W., Stephens D.S. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect. Immun. 2004, 72:371-380.